Connect Biopharma Holdings Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €54.50M +170.6% -€25.72M -43.7% -47.2% +1.8 pp N/A N/A
    (estimated) €20.14M +41.2% -€45.64M +18.7% -226.6% +0.43 pp N/A N/A
    (estimated) €14.26M +65.0% -€38.44M -5.3% -269.5% +2.0 pp N/A N/A
    (estimated) €8.64M +∞% -€40.61M -7.6% -469.7% -4.7 pp N/A N/A
    (estimated) €0.00 -100.0% -€43.96M +227.7% N/A N/A N/A
    €22.35M +∞% -€13.42M -73.7% -60.0% -0.60 pp -€19.63M -52.0% -87.8% -0.88 pp
    €0.00 +NaN% -€51.08M -48.9% N/A -€40.89M -49.9% N/A
    €0.00 +NaN% -€99.94M -43.3% N/A -€81.54M +21.6% N/A
    €0.00 +NaN% -€176.16M +70.6% N/A -€67.05M +235.7% N/A
    €0.00 +NaN% -€103.27M +400.8% N/A -€19.97M +79.8% N/A
    €0.00 -€20.62M N/A -€11.11M N/A

    Notifications